SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Thursday 19 November 2026
News from the 24 hours to Thursday morning, 19 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on a guidance cut that sent the shares lower and put the orthopaedics business under scrutiny. That was partly offset by directors buying ADSs and Barclays raising its price target.
What drove it
- guidance cut
- director share purchases
- Barclays price target
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 13 Nov | −5.7 | 3 |
| Sat 14 Nov | 0.0 | 1 |
| Tue 17 Nov | +2.0 | 2 |
| Wed 18 Nov | +4.8 | 3 |
| Thu 19 Nov | −2.0 | 3 |
3 stories · 3 headlines · strongest first
Pharma and healthcare on 19 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew lowers 2026 guidance and ends talks with J&J −4.71 headline today · 24 in all, since 9 October · A piece looks at Smith & Nephew's share slide after the guidance cut and the outlook for its orthopaedics unit. | ||
| −9.7 | Share price fell after the firm lowered its outlook; orthopaedics under scrutiny. | |
| Barclays raises Smith & Nephew price target to GBP10.40 +7.01 headline today · Barclays lifted its price target on Smith & Nephew to GBP10.40. | ||
| +7.0 | Barclays lifted its price target, signalling analyst optimism on the shares. | |
| Smith & Nephew director share purchases under dividend plan +3.61 headline today · 2 in all, since 13 November · Smith & Nephew disclosed director and PDMR purchases of ADSs. | ||
| +5.8 | Insiders buying American depositary shares shows personal confidence in the business. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.